Skip to main content
SpringerLink
Log in

Using Continuous Glucose Monitoring for Patients Who Have Undergone Metabolic Surgery

  • Chapter
  • First Online:
Continuous Glucose Monitoring

Abstract

Diabetes mellitus (DM) is a chronic disease, and its treatment measures include diet therapy, moderate exercise, medication, glucose monitoring, and diabetes education. Over the past decade, metabolic surgery has become an important means for treating obese patients with type 2 diabetes mellitus (T2DM) that makes long-term remission or even reversal possible. Although metabolic surgery can significantly improve the overall blood glucose levels and effectively reduce the glycated hemoglobin A1c (HbA1c), the improvement of glucose variability varies after different surgical procedures. Continuous glucose monitoring (CGM) is an effective means to evaluate glucose variability. We previously compared the preoperative and 1-year postoperative CGM data of 43 obese patients with type 2 diabetes who underwent Roux-en-Y gastric bypass (RYGB), and we found patients’ HbA1c levels were improved after the operation but the mean amplitude of glycemic excursion (MAGE) levels was not. Thus, postoperative glucose variability after RYGB and its interventions remain to be major challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101. https://doi.org/10.1056/NEJMoa0908292.

    Article  PubMed  CAS  Google Scholar 

  2. Hou X, Lu J, Weng J, Ji L, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, Yang Z, Yang W, Jia W, China National Diabetes and Metabolic Disorders Study Group. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PloS One. 2013;8:e57319. https://doi.org/10.1371/journal.pone.0057319.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76. https://doi.org/10.1056/NEJMoa1200225.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85. https://doi.org/10.1056/NEJMoa1200111.

    Article  PubMed  CAS  Google Scholar 

  6. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31(Suppl 2):290–6. https://doi.org/10.2337/dc08-s271.

    Article  Google Scholar 

  7. Yu H, Zhang L, Bao Y, Zhang P, Tu Y, Di J, Han X, Han J, Jia W. Metabolic syndrome after Roux-en-Y gastric bypass surgery in Chinese obese patients with type 2 diabetes. Obes Surg. 2016;26:2190–7. https://doi.org/10.1007/s11695-016-2074-7.

    Article  PubMed  Google Scholar 

  8. Xu H, Zhang P, Han X, Yu H, Di J, Zou J, Wang Y, Qian Y, Tu Y, Bao Y, Yi H, Guan J, Yin S, Jia W. Sex effect on obesity indices and metabolic outcomes in patients with obese obstructive sleep apnea and type 2 diabetes after laparoscopic Roux-en-Y gastric bypass surgery: a preliminary study. Obes Surg. 2016;26:2629–39. https://doi.org/10.1007/s11695-016-2140-1.

    Article  PubMed  Google Scholar 

  9. Zhang H, Di J, Yu H, Han X, Li K, Zhang P. The short-term remission of diabetic nephropathy after Roux-en-Y gastric bypass in Chinese patients of T2DM with obesity. Obes Surg. 2015;25:1263–70. https://doi.org/10.1007/s11695-015-1666-y.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yu H, Chen J, Lu J, Bao Y, Tu Y, Zhang L, Zhang P, Jia W. Decreased visceral fat area correlates with improved arterial stiffness after Roux-en-Y gastric bypass in Chinese obese patients with type 2 diabetes mellitus: a 12-month follow-up. Surg Obes Relat Dis. 2016;12:550–5. https://doi.org/10.1016/j.soard.2015.09.003.

    Article  PubMed  Google Scholar 

  11. Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33:1933. https://doi.org/10.2337/dc10-0554.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zimmet P, Alberti KG, Rubino F, Dixon JB. IDF’s view of bariatric surgery in type 2 diabetes. Lancet. 2011;378:108–10. https://doi.org/10.1016/S0140-6736(11)61027-1.

    Article  PubMed  Google Scholar 

  13. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE, Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: A Joint Statement by international diabetes organizations. Diabetes Care. 2016;39:861–77. https://doi.org/10.2337/dc16-0236.

    Article  PubMed  CAS  Google Scholar 

  14. Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H. Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg. 2007;17:592–4.

    Article  PubMed  Google Scholar 

  15. Hanaire H, Bertrand M, Guerci B, Anduze Y, Guillaume E, Ritz P. High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass. Diabetes Technol Ther. 2011;13:625–30. https://doi.org/10.1089/dia.2010.0203.

    Article  PubMed  CAS  Google Scholar 

  16. Kefurt R, Langer FB, Schindler K, Shakeri-Leidenmuhler S, Ludvik B, Prager G. Hypoglycemia after Roux-en-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test. Surg Obes Relat Dis. 2015;11:564–9. https://doi.org/10.1016/j.soard.2014.11.003.

    Article  PubMed  Google Scholar 

  17. Abrahamsson N, Eden Engstrom B, Sundbom M, Karlsson FA. Hypoglycemia in everyday life after gastric bypass and duodenal switch. Eur J Endocrinol. 2015;173:91–100. https://doi.org/10.1530/EJE-14-0821.

  18. Marfella R, Barbieri M, Ruggiero R, Rizzo MR, Grella R, Mozzillo AL, Docimo L, Paolisso G. Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients. Diabetes Care. 2010;33:287–9. https://doi.org/10.2337/dc09-1343.

    Article  PubMed  CAS  Google Scholar 

  19. Chinese Diabetes Society. Standards of care for type 2 diabetes in China (2013). Chin J Endocrinol Metab. 2014;30:893–942. https://doi.org/10.3760/cma.j.issn.1000-6699.2014.10.020.

    Article  Google Scholar 

  20. Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care. 2009;32:1188–93. https://doi.org/10.2337/dc09-0076.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yu H, Zhou J, Bao Y, Pin Z, Lu W, Jia W. “Dual-remission” after Roux-en-Y gastric bypass surgery: glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes. Surg Obes Relat Dis. 2016;12:1312–9. https://doi.org/10.1016/j.soard.2015.10.076.

  22. Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol. 2009;297:G950–7. https://doi.org/10.1152/ajpgi.00253.2009.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009;296:E985–92. https://doi.org/10.1152/ajpendo.00004.2009.

    Article  PubMed  CAS  Google Scholar 

  24. Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC. Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis. 2013;9:26–31. https://doi.org/10.1016/j.soard.2011.11.023.

    Article  PubMed  Google Scholar 

  25. Tramunt B, Vaurs C, Lijeron J, Guillaume E, Ritz P, Diméglio C, Hanaire H. Impact of carbohydrate content and glycemic load on postprandial glucose after Roux-en-Y gastric bypass. Obes Surg. 2016;26:1487–92. https://doi.org/10.1007/s11695-015-1930-1.

    Article  PubMed  Google Scholar 

  26. Ritz P, Vaurs C, Bertrand M, Anduze Y, Guillaume E, Hanaire H. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring. Diabetes Technol Ther. 2012;14:736–40. https://doi.org/10.1089/dia.2011.0302.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University, Affiliated Sixth People’s Hospital, Shanghai, China

    H. Y. Yu & Y. Bao

Authors
  1. H. Y. Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Bao .

Editor information

Editors and Affiliations

  1. Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

    Weiping Jia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yu, H.Y., Bao, Y. (2018). Using Continuous Glucose Monitoring for Patients Who Have Undergone Metabolic Surgery. In: Jia, W. (eds) Continuous Glucose Monitoring. Springer, Singapore. https://doi.org/10.1007/978-981-10-7074-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7074-7_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7073-0

  • Online ISBN: 978-981-10-7074-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation